Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US
Open Access
- 3 April 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (4) , e238585
Abstract
Dual antiplatelet therapy (DAPT) with a platelet ADP P2Y12 receptor (P2Y12) inhibitor plus aspirin is critical to prevent major adverse cardiovascular events (MACE) following acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI).1 For patients with ACS, the guidelines recommend DAPT for at least 1 year after PCI.1 Clopidogrel, prasugrel, and ticagrelor are the 3 most prescribed oral P2Y12 inhibitors in the US.Keywords
This publication has 47 references indexed in Scilit:
- MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel – the European MULTIPRAC RegistryEuropean Heart Journal: Acute Cardiovascular Care, 2014
- No free lunches: balancing bleeding and efficacy with ticagrelorEuropean Heart Journal, 2011
- An automated database case definition for serious bleeding related to oral anticoagulant usePharmacoepidemiology and Drug Safety, 2011
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialThe Lancet, 2010
- PrasugrelCirculation, 2010
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionJACC, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007